New patent expiration for Eagle Pharms drug RYANODEX
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. […]
New patent expiration for Eagle Pharms drug RYANODEX Read Post »
Patent Expiration
New patent expiration for Galderma Labs drug EPIDUO
Annual Drug Patent Expirations for EPIDUO Epiduo is a drug marketed by Galderma Labs Lp and Galderma Labs and is
New patent expiration for Galderma Labs drug EPIDUO Read Post »
New patent expiration for Galderma Labs drug EPIDUO FORTE
Annual Drug Patent Expirations for EPIDUO+FORTE Epiduo Forte is a drug marketed by Galderma Labs and is included in one
New patent expiration for Galderma Labs drug EPIDUO FORTE Read Post »
New patent expiration for Sanofi Aventis drug OFORTA
Annual Drug Patent Expirations for OFORTA Oforta is a drug marketed by Sanofi Aventis Us and is included in one
New patent expiration for Sanofi Aventis drug OFORTA Read Post »
New patent expiration for Mylan Speciality drug TOBI PODHALER
Annual Drug Patent Expirations for TOBI+PODHALER Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in
New patent expiration for Mylan Speciality drug TOBI PODHALER Read Post »
Drug Patent Expirations for the Week of December 18, 2022
TOBI PODHALER (tobramycin) Mylan speciality lp Patent: 9,421,166 Expiration: Dec 19, 2022 See More … For more information on how
Drug Patent Expirations for the Week of December 18, 2022 Read Post »
Drug Patent Expirations for the Week of December 18, 2022
TOBI PODHALER (tobramycin) Mylan speciality lp Patent: 9,421,166 Expiration: Dec 19, 2022 See More … For more information on how
Drug Patent Expirations for the Week of December 18, 2022 Read Post »
New patent expiration for Thea Pharma drug ZIOPTAN
Annual Drug Patent Expirations for ZIOPTAN Zioptan is a drug marketed by Thea Pharma and is included in one NDA.
New patent expiration for Thea Pharma drug ZIOPTAN Read Post »
New patent expiration for Tersera drug VARUBI
Annual Drug Patent Expirations for VARUBI Varubi is a drug marketed by Tersera and is included in two NDAs. It
